BD FACSDiscover™ S8 Cell Sorter

Project ID: NIH-NOI-26-PCA-NIDCR-01222 FederalOpportunitiesSpecial Notice

Overview

Agency	NIH Office of Logistics and Acquisition Operations
Deadline	06/25/26
Posted	06/15/26
Estimated Value	$850,000 - $1,400,000 (AI estimate)
Set Aside	None
NAICS	334516 - Analytical Laboratory Instrument Manufacturing
PSC	6640 - Laboratory Equipment And Supplies
Location	Bethesda, MD 20892 United States

Description

Primary Latest Change

Summary

Department of Health and Human Services (HHS) National Institutes of Health (NIH) Office of Logistics and Acquisition Operations (OLAO) For: National Institute of Dental and Craniofacial Research (NIDCR) Division of Intramural Research (DIR) Combined Technical Research Core (CTRC) 2. Action Being Announced This is a notice of intent, and not a request for competitive quotations, proposals, or bids. The National Institutes of Health (NIH), on behalf of the National Institute of Dental and Craniofacial Research (NIDCR), intends to negotiate and award a firm-fixed-price sole source contract to: Becton, Dickinson and Company / BD Biosciences for the acquisition of one (1) BD FACSDiscoverTM S8 Cell Sorter, including required configuration, delivery, installation, biosafety-compliant hood, and standard warranty coverage.

Project Number

PCA-NIDCR-01222

Project Title

BD FACSDiscoverTM S8 Cell Sorter 3. Statutory Authority The Government intends to award this requirement on a sole source basis pursuant to: - 41 U.S.C. 3304(a)(1), as implemented by FAR 6.302-1, Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements; and - as applicable to this acquisition, 41 U.S.C. 1901 and FAR 13.501(a)(1)(ii). This requirement will be processed as an open-market acquisition. 4. Description of Requirement The National Institute of Dental and Craniofacial Research (NIDCR), Division of Intramural Research (DIR), Combined Technical Research Core (CTRC), requires the acquisition of a highly specialized commercial laboratory instrument to replace aging and end-of-life cell sorting instruments and to provide advanced capabilities necessary to support current and future NIH intramural research. The required instrument must provide, at a minimum, the following capabilities: - Cell sorting capability for high-parameter research applications; - Spectral flow cytometry capability; - Integrated real-time imaging during acquisition and/or sorting; - Ability to analyze and sort cells based on fluorescence/spectral signatures, morphology, and image-derived parameters; - Support for rare-cell sorting; - Support for index sorting and plate sorting; and - A biosafety-compliant configuration suitable for sorting human cells in NIH research environments. The anticipated delivery period is 60 to 90 days after award for delivery, installation, and acceptance. The acquisition includes a one-year warranty following installation and acceptance.

Summary (Newest Update)

Background The Department of Health and Human Services (HHS), through the National Institutes of Health (NIH) and specifically the National Institute of Dental and Craniofacial Research (NIDCR), is seeking to acquire a highly specialized commercial laboratory instrument. This acquisition aims to replace aging and end-of-life cell sorting instruments and provide advanced capabilities necessary to support current and future NIH intramural research. The contract is intended for Becton, Dickinson and Company / BD Biosciences, which has previously supplied similar instruments to the NIH. Work Details The contract involves the acquisition of one (1) BD FACSDiscover™ S8 Cell Sorter, which must include the following capabilities: 1. Cell sorting capability for high-parameter research applications; 2. Spectral flow cytometry capability; 3. Integrated real-time imaging during acquisition and/or sorting; 4. Ability to analyze and sort cells based on fluorescence/spectral signatures, morphology, and image-derived parameters; 5. Support for rare-cell sorting; 6. Support for index sorting and plate sorting; 7. A biosafety-compliant configuration suitable for sorting human cells in NIH research environments. The acquisition also includes required configuration, delivery, installation, a biosafety-compliant hood, and standard warranty coverage. Period of Performance The anticipated delivery period is 60 to 90 days after award for delivery, installation, and acceptance. Place of Performance The product will be delivered to the National Institute of Dental and Craniofacial Research (NIDCR) at the NIH. Bidder Requirements Bidders must demonstrate their ability to provide an equivalent commercially available instrument that satisfies all minimum requirements identified in this notice. Capability statements must include product name and manufacturer, technical specifications, descriptive literature or brochures, an explanation of how the product meets each required salient characteristic, and evidence of availability of a biosafety-compliant configuration suitable for NIH use.

Contacts

Contact name	Linda Smith
Contact email	linda.smith2@nih.gov
Contact phone	None
Secondary contact name	Danielle Tines
Secondary contact email	danielle.tines@nih.gov
Secondary contact phone	None